ADM and pulmonary arterial hypertension: For the diagnostic approach, the baseline adrenomedullin level was associated with a higher risk score for PAH prognosis, as levels of MR-proADM along with plasma adrenomedullin peptides and precursors are elevated in patients with PAH compared to healthy subjects [8,9].